The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Journal club: STEP 3 and the intensive behavioural therapy floor

This is a generated summary. It shows the 5 most-liked posts from a topic of 11, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
LS
l.solbergTL211 Oct 2025#1

Posting this under the heading it deserves: Journal club: STEP 3 and the intensive behavioural therapy floor Everything below is what sits behind that.

Two things I would like separated before anyone answers on STEP 3, because they get bundled and then argued about as one thing.

The first is descriptive: what has actually been observed, by whom, and how. The second is causal: why. I am asking about the first only.

38 likes 10mo
CL
c.lundgrenTL216 Feb 2026#5
dr_okonkwo, post #2: Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. Old habit: I write down the expected answer before I calculate it. Go to post

The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.

The general answer and the answer for your case may diverge here.

27 likes in reply to #2 5mo
CC
c.cardosoTL227 Apr 2026#8
dr_okonkwo, post #2: Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. Old habit: I write down the expected answer before I calculate it. Go to post

I read post #6 twice before replying, because I had assumed the opposite.

The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.

13 likes in reply to #2 3mo
CL
customs_ledgerTL3Regular9 Jun 2026 · edited#10

I had written a reply contradicting post #6 and deleted it. Here is what survived.

On STEP 3, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting bit.

If you can post the two or three numbers you are working from, several people here will check the arithmetic rather than argue about the conclusion.

21 likes 2mo
DA
d.achebeTL230 Jun 2026#11
PharmNotes_Whitfield, post #4: The strongest argument against my own position on STEP 3, stated as well as I can state it, since nobody else has yet. Go to post

STEP 3 is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is being asked for.

17 likes in reply to #4 28d

Read the full topic (11 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Journal club: the retatrutide phase 2 obesity paper
Journal club: the retatrutide phase 2 obesity paper — setting out what I have, and where I think it stops being reliable. Collecting what is known about retatrutide phase 2 obesity paper in one place, because…
LFVDAERASV+7 11 33k 7mo
Journal club: STEP-HFpEF and symptom endpoints
Journal club: STEP-HFpEF and symptom endpoints — setting out what I have, and where I think it stops being reliable. The question about step-hfpef and symptom endpoints that I actually want answered is the…
MREPAKTWJD+18 22 2.5k 11mo
About the Journal club category
Our recurring session. One named paper per topic, methods first, conclusions last. Everyone reads before posting. This post is a community wiki: any member at trust level 3 or above can edit it, and every…
KHSDEMSCA+2 6 12k 16mo
Journal club: STEP 1 and the treatment-policy estimand
Journal club: STEP 1 and the treatment-policy estimand Writing it up because I had to work it out twice and would rather nobody else did. Session topic: STEP 1 ( N Engl J Med , 2021). Please read it before…
ZNBSRTW 3 11k 9h
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field
Posting this under the heading it deserves: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Everything below is what sits behind that. Collecting what is known about SURMOUNT-OSA in one place,…
CIRCBPMN+47 51 617 16mo

Related topics — sharing the tags randomised trial, journal club, effect size

TopicParticipantsRepliesViewsActivity
What I would record differently if I started again
Asking directly, because I could not find a straight answer: What I would record differently if I started again Asking about the phase almost nobody writes about. The material here on losing is good. The…
MICLVK 2 12k 5mo
A well-designed study with a badly written abstract
Posting this under the heading it deserves: A well-designed study with a badly written abstract Everything below is what sits behind that. Reading back through what has been written here about well-designed…
RCMICBMRPN+117 128 7.2k 14mo
Journal club: semaglutide in MASH, and surrogate endpoints — does this still hold?
Journal club: semaglutide in MASH, and surrogate endpoints — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. A narrow question about semaglutide…
BDBEMVD 3 28k 6mo
Measurement error in home scales, with a worked standard deviation — a second dataset
Measurement error in home scales, with a worked standard deviation — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Measurement error in home…
AKKSA 2 13k 7mo
Journal club: how we handle discontinuation in obesity trials
On the subject in the title: Journal club: how we handle discontinuation in obesity trials Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it before…
LSCLPM 2 1.9k 12mo